文献速递慢性肾脏病肾小球疾病

可溶性尿激酶型纤溶酶原激活物受体与中国慢性肾脏病患者终末期肾病风险

Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该研究在中国慢性肾脏病多中心队列中检测2391例患者的血清suPAR水平,中位随访54.8个月期间发生407例终末期肾病事件。校正包括基线eGFR分类在内的混杂因素后,血清suPAR最高三分位组较最低三分位组ESRD风险独立增加,HR为1.53(95%CI 1.10-2.12);在肾小球肾炎病因患者中该关联同样独立存在,HR为1.61(95%CI 1.03-2.53)。

要点

  • 血清suPAR升高与中国CKD患者ESRD风险独立相关,最高三分位组HR 1.53。
  • 肾小球肾炎病因患者中suPAR与ESRD风险的关联亦独立存在,HR 1.61。
  • suPAR或可作为CKD进展至ESRD的风险分层生物标志物。

核心结论

  • 循环suPAR水平与中国CKD患者进展至ESRD的风险独立相关,尤其在肾小球肾炎病因患者中。

研究设计与样本

  • 多中心中国慢性肾脏病队列研究,共纳入2391例CKD患者,检测血清suPAR浓度,采用Cox比例风险回归模型分析其与预设终点ESRD的关联。

主要发现

  • 中位随访54.8个月(四分位距47.5-62.2)期间共发生407例ESRD事件。
  • 校正包括基线eGFR分类在内的潜在混杂因素后,血清suPAR最高三分位组(≥3904 pg/mL)较最低三分位组(<2532 pg/mL)ESRD风险增加,HR为1.53(95%CI 1.10-2.12)。
  • 按CKD病因分层,肾小球肾炎患者中血清suPAR最高三分位组较低三分位组ESRD风险增加,HR为1.61(95%CI 1.03-2.53)。

临床怎么用

  • 在CKD患者中可检测血清suPAR水平,辅助识别ESRD进展高风险个体,尤其肾小球肾炎病因患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Soluble urokinase-type plasminogen activator receptor (suPAR), a marker of immune activation, was shown to be associated with outcomes and kidney disease among various patient populations. The prognostic role of circulating suPAR levels in patients with chronic kidney disease (CKD) needs to be investigated in a cohort with large sample size of renal diseases. METHODS: We measured serum suPAR concentration in 2391 CKD patients in the multicenter Chinese Cohort Study of Chronic Kidney Disease, and investigated the association of serum suPAR with the prespecified endpoint event, end-stage renal disease (ESRD), using Cox proportional hazards regression model. RESULTS: Altogether, 407 ESRD events occurred during the median follow-up of 54.8 (interquartile range: 47.5-62.2) months. The higher levels of serum suPAR were independently associated with increased risk of incident ESRD after adjusting for potential confounders including the baseline estimated glomerular filtration rate categories, with the hazard ratios (HRs) of 1.53 [95% confidence intervals (CIs) 1.10-2.12] for the top tertile (≥3904 pg/mL) compared with the bottom tertile (<2532 pg/mL). When stratified by the etiologies of CKD, among patients with glomerulonephritis (GN), serum suPAR levels were also independently associated with the higher risk of ESRD, with an HR of 1.61 (95% CI 1.03-2.53) in the top tertile compared with the bottom tertile. CONCLUSIONS: Circulating suPAR level was independently associated with an increased risk of progression to ESRD in Chinese CKD patients, especially in those with an etiology of GN.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Lv L, Wang F, Wu L, et al. Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease. Nephrol Dial Transplant. 2020. PMID: 30124995. doi:10.1093/ndt/gfy265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。